Investing.com - VBI Vaccines reported on Thursday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
VBI Vaccines announced earnings per share of $-0.090 on revenue of $317K. Analysts polled by Investing.com anticipated EPS of $-0.070 on revenue of $1.82M.
VBI Vaccines shares are down 4.96% from the beginning of the year , still down 82.28% from its 52 week high of $3.41 set on Wednesday, December 1, 2021.
VBI Vaccines shares lost 0.05% in intra-day trade the report.
VBI Vaccines follows other major Healthcare sector earnings this month
VBI Vaccines's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar